Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin A Nephropathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT00368264
What this trial is testing

TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Medical University of Vienna 1
Testing effectiveness (Phase 2)Looking for participantsNCT07582133
What this trial is testing

A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 380
Testing effectiveness (Phase 2)Study completedNCT02942381
What this trial is testing

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Who this might be right for
IgA PatientsHydroxychloroquine
Peking University First Hospital 60
Not applicableNot Yet RecruitingNCT07649538
What this trial is testing

Mediators of Loin Pain in IgA Nephropathy

Who this might be right for
IgA Nephropathy (IgAN)
University of Leicester 40
Testing effectiveness (Phase 2)Looking for participantsNCT07606352
What this trial is testing

Safety and Efficacy of STL303 In Patients With Primary Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgAN
Sitala Bio LTD 15
Not applicableAvailableNCT07319585
What this trial is testing

Managed Access Programs for EXV811, Atrasentan

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals
Very early researchEnrolling By InvitationNCT07135219
What this trial is testing

Cizutamig in Patients With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A Nephropathy (IgAN)
Peking University First Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Testing effectiveness (Phase 2)Study completedNCT00113217
What this trial is testing

Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaKidney Cancer
M.D. Anderson Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT00831844
What this trial is testing

Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Adult RhabdomyosarcomaAdult Synovial SarcomaChildhood Hepatoblastoma+13 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)Study completedNCT04718584
What this trial is testing

The Efficacy and Safety of LDP in Patients With Urinary and Male Genital Tumors

Who this might be right for
Bladder CancerRenal CarcinomaAdvanced Penile Carcinoma
Dragonboat Biopharmaceutical Company Limited 27
Large-scale testing (Phase 3)Study completedNCT00437463
What this trial is testing

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Who this might be right for
Glomerulonephritis
Sanofi 60
Early research (Phase 1)Ended earlyNCT03343613
What this trial is testing

LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerRenal Cell Carcinoma+1 more
Eli Lilly and Company 60
Not applicableStudy completedNCT00004305
What this trial is testing

Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis

Who this might be right for
IGA Glomerulonephritis
National Center for Research Resources (NCRR) 105
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Large-scale testing (Phase 3)Active Not RecruitingNCT06564142
What this trial is testing

Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)

Who this might be right for
Immunoglobulin A Nephropathy
Alpine Immune Sciences Inc, A Subsidiary of Vertex 605
Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07785128
What this trial is testing

Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA Nephropathy

Who this might be right for
IgA Nephropathy
Shaheed Suhrawardy Medical College and Hospital 104
Large-scale testing (Phase 3)Looking for participantsNCT07024563
What this trial is testing

Study of Ravulizumab in Pediatric Participants With Primary IgAN

Who this might be right for
IgANIgAVNImmunoglobulin A Nephropathy+3 more
Alexion Pharmaceuticals, Inc. 36
Large-scale testing (Phase 3)UnknownNCT02187900
What this trial is testing

Treatment of IgAN With Multi-glycoside of Tripterygium Wilfordii HOOK. f.

Who this might be right for
IgA Nephropathy
Second Xiangya Hospital of Central South University 300
Next Page